- Home
- PR vs HOLX Comparison
PR vs HOLX Comparison
Compare PR & HOLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PR | HOLX |
|---|---|---|
| Founded | 2015 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Medical Electronics |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.6B | 16.9B |
| IPO Year | 2016 | 1995 |
Fundamental Metrics
Financial Performance| Metric | PR | HOLX |
|---|---|---|
| Price | $20.55 | $76.02 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 19 | 13 |
| Target Price | $22.35 | ★ $77.89 |
| AVG Volume (30 Days) | 11.6M | ★ 15.6M |
| Earning Date | 05-06-2026 | 04-30-2026 |
| Dividend Yield | ★ 3.07% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 1.28 | 0.79 |
| Revenue | ★ $5,065,211,000.00 | $4,100,500,000.00 |
| Revenue This Year | $20.94 | $4.74 |
| Revenue Next Year | $7.51 | $5.03 |
| P/E Ratio | ★ $16.28 | $96.23 |
| Revenue Growth | 1.29 | ★ 1.74 |
| 52 Week Low | $11.58 | $51.90 |
| 52 Week High | $21.99 | $76.07 |
Technical Indicators
Market Signals| Indicator | PR | HOLX |
|---|---|---|
| Relative Strength Index (RSI) | 54.10 | 69.09 |
| Support Level | $19.08 | $75.10 |
| Resistance Level | $21.99 | N/A |
| Average True Range (ATR) | 0.55 | 0.19 |
| MACD | -0.10 | 0.03 |
| Stochastic Oscillator | 58.95 | 95.19 |
Price Performance
Historical ComparisonAbout PR Permian Resources Corporation
Permian Resources Corp is an independent oil and natural gas company focused on generating outsized returns to stakeholders through the responsible acquisition, optimization, and development of oil and liquids-rich natural gas assets. The Company's assets and operations are concentrated in the core of the Permian Basin, and its properties consist of large, contiguous acreage blocks located in West Texas and New Mexico.
About HOLX Hologic Inc.
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.